Alexander Neumeister

About

Alexander Neumeister trained as a concert pianist before he ever picked up a medical textbook. That detail surprises people. Born in Vienna, Austria, he spent his formative years at the keyboard before turning toward medicine, earning his M.D. from the University of Vienna Medical School between 1984 and 1990, then completing psychiatry and neurology residency at the same institution by 1998.

He came to the United States and joined the National Institute of Mental Health in 2001, where his research centered on neuroimaging and genetic studies of mood and anxiety disorders. Faculty appointments at Yale, Mount Sinai, and NYU followed. From 2006 to 2010, he directed the PTSD Research Program at the VA Connecticut Healthcare System in Connecticut, building one of the more serious clinical research efforts in that area. More than 300 peer-reviewed publications carry his name, along with a long record of international lectures.

The Austrian-American physician-scientist and biotechnology executive is now based in Boston, Massachusetts, working across neuroscience, clinical psychopharmacology, and translational research. It's a career that doesn't fit a single category: academic work, clinical practice, and pharmaceutical industry leadership have all been part of it at different points. The range isn't accidental. People who've watched his career note that the same precision he once brought to Schubert he now brings to study design. Whether that's true is hard to verify. What isn't hard to verify is the output.

Expertise

• Neuroscience and neuroimaging research
• Clinical psychopharmacology
• Translational medicine
• Mood and anxiety disorders
• PTSD research and treatment
• Gene therapy clinical development

Industry Experience

Neumeister has served in executive clinical development roles at biotechnology companies. At OliX Pharmaceuticals, his contributions led to a $630 million licensing agreement. Currently at AskBio, Inc., he oversees gene therapy clinical programs, bringing his research expertise to therapeutic development.

Credentials

• M.D., University of Vienna Medical School (1990)
• Psychiatry and Neurology Residency, University of Vienna (1998)
• Former faculty at Yale, Mount Sinai, and NYU medical schools
• Former Director, PTSD Research Program, VA Connecticut Healthcare System
• Over 300 peer-reviewed publications

Links

Professional Profiles

• LinkedIn

Featured In

• Alexander Neumeister on Biography.wiki
• Alexander Neumeister on Boston.wiki

FAQ

Who is Alexander Neumeister?

Alexander Neumeister is an Austrian-American physician-scientist and biotechnology executive specializing in neuroscience, clinical psychopharmacology, and translational research. He has published over 300 peer-reviewed papers and held faculty positions at Yale, Mount Sinai, and NYU medical schools.

What is Alexander Neumeister's area of research?

Neumeister's research focuses on neuroimaging and genetic studies of mood and anxiety disorders, with particular expertise in PTSD research and treatment. He has also worked extensively in clinical psychopharmacology and translational medicine, bridging laboratory findings with patient care.

Where did Alexander Neumeister train?

Neumeister earned his M.D. from the University of Vienna Medical School (1990) and completed his psychiatry and neurology residency training at the same institution by 1998. He was also trained as a professional pianist in Vienna before pursuing medicine.

What has Alexander Neumeister done in the biotechnology industry?

Neumeister has held executive clinical development roles at biotechnology companies. At OliX Pharmaceuticals, his contributions led to a $630 million licensing agreement. He currently works at AskBio, Inc., overseeing gene therapy clinical programs.

Where is Alexander Neumeister located?

Alexander Neumeister is based in Boston, Massachusetts, where he continues his work at the intersection of neuroscience research and biotechnology development.

How many publications does Alexander Neumeister have?

Neumeister has authored over 300 peer-reviewed publications throughout his career, contributing to the scientific literature on psychiatric disorders, brain imaging, and therapeutic development for neuropsychiatric conditions.